Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2025-03-31 00:00:00 ET · period of report 2025-03-27 · accession 0000950170-25-047725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-03-31 | 2025-03-27 | RLAY | Catinazzo Thomas | CFO | S - Sale | $2.84 | -4,864 | 379.1K | -1% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-27 | S | D | 4,566 | $2.84 | 374,567 | D | — | — | (F2) Includes 254,354 shares underlying RSUs. |
| 2 | Common | Common Stock | 2025-03-27 | S | D | 298 | $2.84 | 379,133 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 254,354 shares underlying RSUs. |